These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 575672)

  • 1. [Degree of saturation of urine with calcium oxalate in patients with metabolically active calcium-oxalate urolithiasis].
    Głuszek J; Raszeja-Wanic B; Pupek-Musialik D; Luzna B
    Pol Tyg Lek; 1979 Nov; 34(46):1777-9. PubMed ID: 575672
    [No Abstract]   [Full Text] [Related]  

  • 2. [Comparison of calcium oxalate values as indicators of risk for calcium oxalate calcinosis and the degree of urine saturation in patients with calcium urolithiasis and in healthy patients].
    Głuszek J; Boruczkowska A; Kosicka T; Raszeja-Wanic B
    Pol Tyg Lek; 1989 Feb; 44(9):220-2. PubMed ID: 2813183
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of urine saturation and inhibitory index in patients with calcium oxalate kidney stone and normals.
    Sun CT; Cao LC; Han KH
    Chin Med J (Engl); 1987 Dec; 100(12):935-9. PubMed ID: 3133165
    [No Abstract]   [Full Text] [Related]  

  • 4. Ion binding by small molecular weight substances (1,000-10,000 daltons) in urine.
    Nicar MJ; Holt K; Pak CY
    Invest Urol; 1980 Sep; 18(2):162-4. PubMed ID: 7410030
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Non-medicamentous prevention of calcium oxalate urinary calculi].
    Brundig P; Schulz E; Börner R; Haerting R; Janitzky V
    Z Urol Nephrol; 1989 Jun; 82(6):307-15. PubMed ID: 2763727
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lithogenic risk factors for renal stones in patients with Crohn's disease.
    Buño Soto A; Torres Jiménez R; Olveira A; Fernández-Blanco Herraiz I; Montero García A; Mateos Antón F
    Arch Esp Urol; 2001 Apr; 54(3):282-92. PubMed ID: 11432047
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of semi-empirical and computer derived methods for estimating urinary saturation of calcium oxalate.
    Pak CY; Maalouf NM; Rodgers K; Poindexter JR
    J Urol; 2009 Dec; 182(6):2951-6. PubMed ID: 19846163
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Physico-chemical principles of crystallization processes in the urine].
    Raczka A; Pietrek J
    Postepy Hig Med Dosw; 1981; 34(6):525-37. PubMed ID: 7027226
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical characteristics and pathogenetic mechanisms in hyperuricosuric calcium oxalate renal stone disease.
    Favus MJ; Coe FL
    Scand J Urol Nephrol Suppl; 1980; 53():171-7. PubMed ID: 6937993
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Crystallization properties in urine from calcium oxalate stone formers.
    Tiselius HG; Bek-Jensen H; Fornander AM; Nilsson MA
    J Urol; 1995 Sep; 154(3):940-6. PubMed ID: 7637098
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterogeneous nucleation of calcium oxalate crystals in mammalian urine.
    Khan SR
    Scanning Microsc; 1995 Jun; 9(2):597-614; discussion 614-6. PubMed ID: 8714752
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Resorption of oxalic acid in calcium oxalate nephrolithiasis].
    Müller G; Schütte W; Berg W; Möller T
    Z Urol Nephrol; 1987 Jul; 80(7):391-4. PubMed ID: 3660960
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Physicochemical basis for the formation of calcium oxalate renal stones. Estimation of the degree of urine saturation with the activity product ratio (CPA) (author's transl)].
    Peña JC; Fishleder S; Galván P; Herrera-Acosta J
    Rev Invest Clin; 1981; 33(4):333-41. PubMed ID: 7330508
    [No Abstract]   [Full Text] [Related]  

  • 14. [Risk indicators of urinary calculus formation: value of oxalate and citrate excretion in comparison with the oxalate tolerance value].
    Hannak D; Burczyk U; Bartelt U; Kattermann R
    Urologe A; 1989 Jan; 28(1):20-4. PubMed ID: 2922896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Diclofenac-Na--an alternative treatment possibility in therapy-resistant calcium oxalate urolithiasis?].
    Brundig P; Pirlich W; Börner RH; Wittig E
    Urologe A; 1986 Jul; 25(4):204-8. PubMed ID: 3765223
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Measurements of urinary state of saturation with respect to calcium oxalate and brushite (CaHPO4.2H2O) in renal stone formers.
    Sriboonlue P; Prasongwattana V; Tungsanga K; Sitprija V
    J Med Assoc Thai; 1990 Dec; 73(12):684-9. PubMed ID: 2086716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Pathogenesis of hyperoxalurias and calcium oxalate calculi in intestinal diseases].
    Müller G; Schütte W; Möller T
    Dtsch Z Verdau Stoffwechselkr; 1987; 47(3):105-12. PubMed ID: 3311705
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Comparative study of urinary calcium, oxalate and uric acid in calcium oxalate lithiasis].
    Dumoulin G; Haton D; Wolf JP; Henriet MT; Nguyen NU; Mougin C; Saint-Hillier Y; Combes M; Berthelay S
    Nephrologie; 1984; 5(5):189-91. PubMed ID: 6531054
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular abnormality of urinary glycoprotein crystal growth inhibitor in calcium nephrolithiasis.
    Nakagawa Y; Parks JH; Kézdy FJ; Coe FL
    Trans Assoc Am Physicians; 1985; 98():281-9. PubMed ID: 3842199
    [No Abstract]   [Full Text] [Related]  

  • 20. [Urine saturation with calcium oxalate in urolithiasis].
    Bogado CE; Zanchetta JR
    Medicina (B Aires); 1988; 48(1):39-44. PubMed ID: 3216787
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.